Please use this identifier to cite or link to this item: https://scholarhub.balamand.edu.lb/handle/uob/7674
Title: Nebivolol-Induced Hepatoxicity: A Case Report
Authors: Srour, Lynn
Ali, Majed
Karam, Karam
Fiani, Elias
Affiliations: Faculty of Medicine 
Faculty of Medicine 
Keywords: Nebivolol
Hepatotoxicity
Issue Date: 2024
Publisher: National Library of Meficine
Part of: European Journal of Case Reports in Internal Medicine
Volume: 11
Issue: 11
Abstract: 
Nebivolol is a third-generation beta-blocker known for its high selectivity for beta-1 adrenergic receptors and its unique ability to induce vasodilation via nitric oxide (NO) release. Nebivolol, despite its favourable safety profile, can lead to significant liver injury. We describe the case of a 73-year-old hypertensive patient who developed significant liver enzyme elevations following the addition of nebivolol to her treatment regimen. Comprehensive workup ruled out other causes, leading to a diagnosis of drug-induced hepatotoxicity. Discontinuation of nebivolol resulted in normalization of liver enzymes. This case underscores the importance of monitoring liver function during beta-blocker therapy, particularly with nebivolol.
URI: https://scholarhub.balamand.edu.lb/handle/uob/7674
DOI: 10.12890/2024_004866
Open URL: Link to full text
Type: Journal Article
Appears in Collections:Faculty of Medicine

Show full item record

Record view(s)

9
checked on Jan 2, 2025

Google ScholarTM

Check

Altmetric

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.